Traveling for Care?
Whether you're crossing the country or the globe, we make it easy to access world-class care at Johns Hopkins.
There are two primary goals of treatment of ARVD/C:
Treatment options vary by patient, and are based on a patient’s cardiac test results, medical history, and the presence or absence of genetic mutations. The three most common treatments for arrhythmias are:
There have been no controlled studies to examine the specific effects of exercise, medications, or procedures on the long-term outcome of the disease. Nor have vitamin treatments or alternative therapies been studied. You and your doctor should discuss appropriate guidelines for diet and healthy living, as well as symptoms that could indicate a complication related to the disease.
Some patients will have a stable functioning heart for decades, while others may have spells of arrhythmias that require changes in medication or ablations. Our research has shown that the long-term outlook for most people with ARVD/C is relatively good. Few patients develop such severe dysfunction or frequent episodes of ventricular tachycardia that a heart transplant may be necessary. We believe that most people who die from ARVD/C do so because the condition is not diagnosed and monitored appropriately.